Health professionals: How do you view this new approval
And so when you drink alcohol, it's like, yeah, you're putting a known toxin, low grade, refined, tastes great, right
In mental health, Boehringer Ingelheim entered a new partnership with Sosei Heptares (now Nxera Pharma) located in Tokyo, Japan, and Cambridge, Great Britain, to develop GPR52 agonists for schizophrenia
Anti-Aging: Slows the aging process by protecting cells from damage and supporting skin health
Practical considerations researchers should know Beyond the clinical data, several practical factors influence the CagriSema versus tirzepatide decision that many comparison articles overlook
And for weight-loss drugmakers, every new use could catapult the drugs even further into blockbuster status